Slideshow
Author(s):
Here is evidence that metformin, especially at high doses and for long periods, is associated with increased risk for neurodegenerative diseases and dementia.
Phase 2a Trial to Test Effects of Antiseizure Medication Lamotrigine in Dementia With Lewy Bodies
Episode 126: Exploring the Therapeutic Potential of ATH434 in Multiple System Atrophy
Huntington Agent SAGE-718 to be Discontinued Following Disappointing Phase 2 DIMENSION Trial Results
Episode 122: RNA Therapeutics, Mivelsiran, and Treating Alzheimer Disease
NeuroVoices: Charbel Moussa, PhD, MBBS, on Therapeutic Potential of Nilotinib in Dementia With Lewy Bodies
Phase 3 ARISE Trial of Parkinson Therapy Solengepras Begins Dosing